Association of genetic polymorphisms in the ACE, ApoE, and TGF beta genes with early onset ischemic heart disease.Biggart S., Chin D., Fauchon M., Cardew G., du Fou L., Harker N., Quinn E., Keller C., Vincent R., Mayne L.View abstractAnnotationAssociated with CARDIOVASCULAR: early onset ischemic heart disease..CategoriesDisease & VariantsSourceGAD:117100PubMedEurope PMCClin Cardiol 21:831-836 (1998)Mapped to36
Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease.van Dyck C.H., Gelernter J., MacAvoy M.G., Avery R.A., Criden M., Okereke O., Varma P., Seibyl J.P., Hoffer P.B.View abstractAnnotationNot Associated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117022PubMedEurope PMCArch Neurol 55:1460-1466 (1998)Mapped to12
An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E.Stengard J.H., Weiss K.M., Sing C.F.View abstractAnnotationAssociated with CARDIOVASCULAR: cardiovascular.CategoriesDisease & VariantsSourceGAD:117122PubMedEurope PMCHum Genet 103:234-241 (1998)Mapped to12
The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.Town T., Paris D., Fallin D., Duara R., Barker W., Gold M., Crawford F., Mullan M.View abstractAnnotationAssociated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117152PubMedEurope PMCNeurosci Lett 252:95-98 (1998)Mapped to12
Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort.Sass C., Zannad F., Herbeth B., Salah D., Chapet O., Siest G., Visvikis S.View abstractAnnotationNot Associated with CARDIOVASCULAR: increased wall thickness of carotid and femoral arteries.CategoriesDisease & VariantsSourceGAD:117097PubMedEurope PMCAtherosclerosis 140:89-95 (1998)Mapped to12
Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE.Song Y.Q., Rogaeva E., Premkumar S., Brindle N., Kawarai T., Orlacchio A., Yu G., Levesque G., Nishimura M.[...], St George-Hyslop P.View abstractAnnotationAssociated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117112PubMedEurope PMCNeurosci Lett 250:189-192 (1998)Mapped to12
A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution.Zubenko G.S., Hughes H.B., Stiffler J.S., Hurtt M.R., Kaplan B.B.View abstractAnnotationAssociated with NEUROLOGICAL: Alzheimer`s disease.CategoriesDisease & VariantsSourceGAD:117023PubMedEurope PMCGenomics 50:121-128 (1998)Mapped to12
Genetic association of apolipoprotein E with age-related macular degeneration.Klaver C.C., Kliffen M., van Duijn C.M., Hofman A., Cruts M., Grobbee D.E., van Broeckhoven C., de Jong P.T.View abstractAnnotationAssociated with VISION: macular degeneration.CategoriesDisease & VariantsSourceGAD:117060PubMedEurope PMCAm J Hum Genet 63:200-206 (1998)Mapped to12
Association of apolipoprotein E genotype and intronic polymorphism of the presenilin-1 gene with Alzheimer's disease in elderly Taiwan Chinese.Hu C.J., Sung S.M., Liu H.C., Chang J.G.View abstractAnnotationAssociated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117123PubMedEurope PMCJ Neurol Sci 157:158-161 (1998)Mapped to12
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.Montine K.S., Reich E., Neely M.D., Sidell K.R., Olson S.J., Markesbery W.R., Montine T.J.View abstractAnnotationAssociated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117113PubMedEurope PMCJ Neuropathol Exp Neurol 57:415-425 (1998)Mapped to12
Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.Marz W., Hoffmann M.M., Scharnagl H., Fisher E., Chen M., Nauck M., Feussner G., Wieland H.View abstractAnnotationNot Associated with OTHER: dominant type III hyperlipoproteinemia.CategoriesDisease & VariantsSourceGAD:117062PubMedEurope PMCJ Lipid Res 39:658-669 (1998)Mapped to12
No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.Singleton A.B., Smith G., Gibson A.M., Woodward R., Perry R.H., Ince P.G., Edwardson J.A., Morris C.M.View abstractAnnotationNot Associated with NEUROLOGICAL: Alzheimer`s Disease.CategoriesDisease & VariantsSourceGAD:117024PubMedEurope PMCHum Mol Genet 7:937-939 (1998)Mapped to16
Alpha-1-antichymotrypsin is not associated with the increased frequency of apolipoprotein-E-epsilon-4 allele in elderly non-demented leprosy patients.Endoh M., Ueki A., Takahashi K., Yamanaka H., Izumi S., Tabira T.View abstractAnnotationNot Associated with OTHER: non-demented leprosy patients.CategoriesDisease & VariantsSourceGAD:117050PubMedEurope PMCDement Geriatr Cogn Disord 9:26-28 (1998)Mapped to12
A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.Lambert J.C., Pasquier F., Cottel D., Frigard B., Amouyel P., Chartier-Harlin M.C.View abstractAnnotationAssociated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117085PubMedEurope PMCHum Mol Genet 7:533-540 (1998)Mapped to12
A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Lendon C., Han S.W., Morris J.C.[...], Valdivieso F.View abstractAnnotationAssociated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117153PubMedEurope PMCNat Genet 18:69-71 (1998)Mapped to12
The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease.Kessler C., Spitzer C., Stauske D., Mende S., Stadlmuller J., Walther R., Rettig R.View abstractAnnotationAssociated with CARDIOVASCULAR: stroke.CategoriesDisease & VariantsSourceGAD:117048PubMedEurope PMCArterioscler Thromb Vasc Biol 17:2880-2884 (1997)Mapped to12
Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease.Clatworthy A.E., Gomez-Isla T., Rebeck G.W., Wallace R.B., Hyman B.T.View abstractAnnotationNot Associated with NEUROLOGICAL: Alzheimer`s Disease.CategoriesDisease & VariantsSourceGAD:117042PubMedEurope PMCArch Neurol 54:1289-1292 (1997)Mapped to12
Association of bone mineral density with apolipoprotein E phenotype.Shiraki M., Shiraki Y., Aoki C., Hosoi T., Inoue S., Kaneki M., Ouchi Y.View abstractAnnotationAssociated with METABOLIC: bone mineral density.CategoriesDisease & VariantsSourceGAD:117132PubMedEurope PMCJ Bone Miner Res 12:1438-1445 (1997)Mapped to12
No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.Helisalmi S., Mannermaa A., Lehtovirta M., Ryynanen M., Riekkinen P. Sr., Soininen H.View abstractAnnotationNot Associated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117078PubMedEurope PMCNeurosci Lett 231:56-58 (1997)Mapped to12
Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease.Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., Thomas R.G., Thal L.J., Katzman R.View abstractAnnotationAssociated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117143PubMedEurope PMCNeurology 49:56-61 (1997)Mapped to12
Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome.Farrer M.J., Crayton L., Davies G.E., Oliver C., Powell J., Holland A.J., Kessling A.M.View abstractAnnotationAssociated with OTHER: Down syndrome.CategoriesDisease & VariantsSourceGAD:117213PubMedEurope PMCNeuroreport 8:1645-1649 (1997)Mapped to12
No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples.Fallin D., Gauntlett A.C., Scibelli P., Cai X., Duara R., Gold M., Crawford F., Mullan M.View abstractAnnotationNot Associated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117127PubMedEurope PMCGenet Epidemiol 14:299-305 (1997)Mapped to12
The apolipoprotein E epsilon 4 allele is not associated with early onset temporal lobe epilepsy.Blumcke I., Brockhaus A., Scheiwe C., Rollbrocker B., Wolf H.K., Elger C.E., Wiestler O.D.View abstractAnnotationNot Associated with OTHER: early onset temporal lobe epilepsy..CategoriesDisease & VariantsSourceGAD:117115PubMedEurope PMCNeuroreport 8:1235-1237 (1997)Mapped to12
Genetic variations of the apo E-CI-CII cluster gene in Koreans.Hong S.H., Kang B.Y., Oh J.H., Kim J.Q., Lee C.C.View abstractAnnotationNot Associated with METABOLIC: Plasma Lipid Levels.CategoriesDisease & VariantsSourceGAD:117040PubMedEurope PMCClin Biochem 30:215-219 (1997)Mapped to12
Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.Mann D.M., Iwatsubo T., Pickering-Brown S.M., Owen F., Saido T.C., Perry R.H.View abstractAnnotationAssociated with NEUROLOGICAL: Alzheimer's Disease.CategoriesDisease & VariantsSourceGAD:117109PubMedEurope PMCNeurosci Lett 221:81-84 (1997)Mapped to12